Clovis Oncology reported $185.54M in Current Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Abbvie ABBV:US $ 26509M 1419M
Acadia Pharmaceuticals ACAD:US $ 542.22M 75.6M
Acorda Therapeutics ACOR:US $ 80.46M 21.7M
Agenus AGEN:US $ 290.48M 41.49M
Agios Pharmaceuticals AGIO:US $ 975.14M 89.09M
Anika Therapeutics ANIK:US $ 165.32M 3.21M
Arrowhead Research ARWR:US $ 417.63M 79.35M
AstraZeneca AZN:LN 22.65B 3.6B
Astrazeneca AZN:US 22.65B 3.6B
Cerulean Pharma CERU:US $ 47.82M 7.48M
Clovis Oncology CLVS:US $ 185.54M 12.55M
Eli Lilly And LLY:US $ 16964.7M 1487.7M
Enanta Pharmaceuticals ENTA:US $ 341.87M 14.91M
Esperion Therapeutics ESPR:US $ 290.82M 38.15M
GlaxoSmithKline GSK:LN 28.99B 10.31B
Halozyme Therapeutics HALO:US $ 988.69M 62.4M
Heron Therapeutics HRTX:US $ 222.59M 31.83M
Insmed INSM:US $ 756.14M 80.9M
Intrexon XON:US $ 154.94M 1.69M
Ligand Pharmaceuticals LGND:US $ 276.07M 188.68M
Merk MRK:US $ 31184M 918M
Mirati Therapeutics MRTX:US $ 1343.12M 164.87M
Neurocrine Biosciences NBIX:US $ 1018.2M 45.4M
Novartis NOVN:VX 37.24B 8.48B
Pfizer PFE:US $ 54420M 5273M
Puma Biotechnology PBYI:US $ 117.57M 22.45M
Rigel Pharmaceuticals RIGL:US $ 138.94M 15.53M
Sangamo Biosciences SGMO:US $ 340.06M 58.7M
Seattle Genetics SGEN:US $ 2771.26M 97.94M
Ultragenyx Pharmaceutical RARE:US $ 707.52M 149.08M
Veracyte VCYT:US $ 238.48M 4.62M
YTE INCY:US $ 3288.09M 169.42M